2Trebing I, Goring HD. Wound healing of chronic legulcers under the influcglce of erysipelas [ J ]. Eur J Dermatol,2004,14:56-57.
3Coste N, Perceau G, Leone J, et al. Osteoarticular complications of erysipelas [ J ]. J Am Acad Dermatol, 2004,50:203 - 209.
4Hedrick J. Acute bacterial skin infectiuns in pediatric medicine:current issues in presentation and treatment[J]. Paediatr Drugs,2003,5 (Suppl) 1:35-46.
5杨健,叶晓光.感染性疾病的皮肤表现与鉴别图谱[M].广州:广东人民出版社,1999.37.
6Buss DH, Cashell AW, O' Connor ML, et al. Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases [J]. Am J Med,1994,96(3) :247-253.
7Perell -Alzamora MR, Santos-Duran JC, S nchez-Barba M,et al.Chnical and epidemiological characteristics of adult patients hospitalized for erysipelas and cellulitis [J].Eur J Clin Microbiol Infect Dis,2012,31(9):2147-2152.
8UK Dermatology Clinical TriMs Network's PATCH Trial Team, Thomas K,Crook A,et al.Prophylactic antibiotics for the prevention of celluhtis (erysipelas) of the leg: results of the UK Dermatology Clinical TriMs Network's PATCH II trial[J]. Br J Dermatol,2012,166(1):169-178.
9Picard D, Klein A, Grigioni S,et al.Risk factors for abscess formation in patients with superficial celluhtis (erysipelas) of the leg[I]. Br J Dermatol,2013,168(4):859-863.
